Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)
概要：Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)（CAS 171088-78-1）是一种化学化合物，分子式为C18H23N5O4S，分子量为405.15 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务，支持克级到吨级规格。
4,5-dihydro-1,3-thiazol-2-amine;4-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-oxobutanoic acid
又称：Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1), 4,5-dihydro-1,3-thiazol-2-amine; 4-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-oxobutanoic acid, 4-[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]-4-oxobutanoic acid--4,5-dihydro-1,3-thiazol-2-amine (1/1), RefChem:330801
| 分子式 | C18H23N5O4S |
|---|---|
| 分子量 | 405.15 g/mol |
| LogP | 1.33562 |
| 拓扑极性表面积 | 131.71 Ų |
| 氢键供体数 | 3 |
| 氢键受体数 | 6 |
| 可旋转键数 | 5 |
| 精确质量 | 405.14706 |
| 重原子数 | 28 |
| 复杂度 | 933.4429 |
化学标识符
| CAS 编号 | 171088-78-1 |
|---|---|
| SMILES | CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)CCC(=O)O.C1CSC(=N1)N |
产品概述
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)（CAS 171088-78-1），分子式为C18H23N5O4S，分子量为405.15 g/mol。IUPAC名：4,5-dihydro-1,3-thiazol-2-amine;4-[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]-4-oxobutanoic acid。
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)化学性质概览
属性洞察：Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的XLogP值为1.33562，表明具有中等亲脂性，在水溶性和膜透过性之间取得平衡。 TPSA为131.71 Ų，处于中等极性范围，在透过性和溶解性之间取得平衡。 根据Lipinski五规则，Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)有3个氢键供体和6个氢键受体，均在类药范围内，提示具有较好的口服生物利用度潜力。
常见问题
常见问题
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的CAS号是多少？
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的CAS号为171088-78-1。
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的分子式是什么？
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的分子式为C18H23N5O4S。
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的分子量是多少？
Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的分子量为405.15 g/mol。
在哪里可以购买Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)？
您可以直接向科弘生物询价Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)的定制合成服务？
是的，科弘生物提供Butanoic acid, 4-((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)amino)-4-oxo-, compd. with 4,5-dihydro-2-thiazolamine (1:1)及相关化合物的定制合成服务。请联系我们并告知您的具体需求，包括数量、纯度和交期。